Lee F. Allen

2012 - AMAG Pharmaceuticals

In 2012, Lee F. Allen earned a total compensation of $1.2M as Former Executive Vice President of Medical Development and Chief Medical Officer at AMAG Pharmaceuticals, a 20% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$210,000
Option Awards$279,528
Salary$375,000
Stock Awards$374,800
Other$7,500
Total$1,246,828

Allen received $375K in salary, accounting for 30% of the total pay in 2012.

Allen also received $210K in non-equity incentive plan, $279.5K in option awards, $374.8K in stock awards and $7.5K in other compensation.

Rankings

In 2012, Lee F. Allen's compensation ranked 5,274th out of 11,487 executives tracked by ExecPay. In other words, Allen earned more than 54.1% of executives.

ClassificationRankingPercentile
All
5,274
out of 11,487
54th
Division
Manufacturing
1,846
out of 4,253
57th
Major group
Chemicals And Allied Products
444
out of 1,203
63rd
Industry group
Drugs
291
out of 925
69th
Industry
Pharmaceutical Preparations
228
out of 700
67th
Source: SEC filing on April 19, 2013.

Allen's colleagues

We found five more compensation records of executives who worked with Lee F. Allen at AMAG Pharmaceuticals in 2012.

2012

William Heiden

AMAG Pharmaceuticals

Chief Executive Officer

2012

Frank Thomas

AMAG Pharmaceuticals

Chief Operating Officer

2012

Christopher White

AMAG Pharmaceuticals

Senior Vice President and Chief Business Officer

2012

Scott Townsend

AMAG Pharmaceuticals

General Counsel

2012

Scott Holmes

AMAG Pharmaceuticals

Chief Accounting Officer

You may also like